Healthcare provider profile · identity verified

Shane Thomas Ridge, D.O.

Family Practice · WESTBROOK, CT · NPI 1780884569

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	603	155
Lisinopril	Lisinopril	451	123
Amlodipine Besylate	Amlodipine Besylate	364	107
Levothyroxine Sodium	Levothyroxine Sodium	323	84
Rosuvastatin Calcium	Rosuvastatin Calcium	274	80
Hydrochlorothiazide	Hydrochlorothiazide	223	66
Metformin Hcl	Metformin Hcl	207	62
Simvastatin	Simvastatin	207	53
Tamsulosin Hcl	Tamsulosin Hcl	199	58
Omeprazole	Omeprazole	167	42
Losartan Potassium	Losartan Potassium	161	44
Metoprolol Succinate	Metoprolol Succinate	159	40
Gabapentin	Gabapentin	153	39
Pantoprazole Sodium	Pantoprazole Sodium	139	41
Fluticasone Propionate	Fluticasone Propionate	135	46
Allopurinol	Allopurinol	134	38
Alprazolam	Alprazolam	132	38
Albuterol Sulfate Hfa	Albuterol Sulfate	117	47
Escitalopram Oxalate	Escitalopram Oxalate	106	32
Zolpidem Tartrate	Zolpidem Tartrate	106	23
Pravastatin Sodium	Pravastatin Sodium	96	25
Jardiance	Empagliflozin	80	20
Furosemide	Furosemide	79	22
Lorazepam	Lorazepam	69	26
Sertraline Hcl	Sertraline Hcl	64	21
Oxycodone Hcl	Oxycodone Hcl	61	12
Duloxetine Hcl	Duloxetine Hcl	57	14
Eliquis	Apixaban	57	16
Buspirone Hcl	Buspirone Hcl	56	suppressed
Finasteride	Finasteride	56	14
Montelukast Sodium	Montelukast Sodium	56	18
Famotidine	Famotidine	53	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	50	13
Alendronate Sodium	Alendronate Sodium	49	15
Trazodone Hcl	Trazodone Hcl	45	18
Metoprolol Tartrate	Metoprolol Tartrate	44	11
Ozempic	Semaglutide	42	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	38	suppressed
Atenolol	Atenolol	37	11
Synthroid	Levothyroxine Sodium	37	12
Clopidogrel	Clopidogrel Bisulfate	36	suppressed
Tramadol Hcl	Tramadol Hcl	36	11
Xarelto	Rivaroxaban	36	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	33	suppressed
Nebivolol Hcl	Nebivolol Hcl	33	suppressed
Benazepril Hcl	Benazepril Hcl	32	suppressed
Diazepam	Diazepam	32	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	32	suppressed
Lovastatin	Lovastatin	32	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	31	suppressed
Mounjaro	Tirzepatide	31	suppressed
Potassium Chloride	Potassium Chloride	31	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	30	suppressed
Citalopram Hbr	Citalopram Hydrobromide	29	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	29	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	29	suppressed
Mirtazapine	Mirtazapine	29	suppressed
Paroxetine Hcl	Paroxetine Hcl	28	suppressed
Meloxicam	Meloxicam	27	12
Carvedilol	Carvedilol	26	11
Doxycycline Hyclate	Doxycycline Hyclate	26	22
Glipizide	Glipizide	25	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	25	suppressed
Chlorthalidone	Chlorthalidone	24	suppressed
Irbesartan	Irbesartan	24	suppressed
Ezetimibe	Ezetimibe	23	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	23	suppressed
Ipratropium Bromide	Ipratropium Bromide	23	suppressed
Metformin Hcl Er	Metformin Hcl	23	suppressed
Prednisone	Prednisone	22	14
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	22	suppressed
Enalapril Maleate	Enalapril Maleate	21	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Morphine Sulfate Er	Morphine Sulfate	21	suppressed
Trulicity	Dulaglutide	21	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Clonazepam	Clonazepam	20	suppressed
Lansoprazole	Lansoprazole	20	suppressed
Symbicort	Budesonide/Formoterol Fumarate	20	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	19	12
Candesartan Cilexetil	Candesartan Cilexetil	19	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	18	suppressed
Primidone	Primidone	18	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	17	suppressed
Glipizide Er	Glipizide	17	suppressed
Januvia	Sitagliptin Phosphate	17	suppressed
Nifedipine Er	Nifedipine	17	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	17	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	17	suppressed
Bupropion Xl	Bupropion Hcl	16	suppressed
Clotrimazole	Clotrimazole	16	suppressed
Terazosin Hcl	Terazosin Hcl	16	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Celecoxib	Celecoxib	15	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	15	suppressed
Methylprednisolone	Methylprednisolone	15	15
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	15
Nystatin	Nystatin	15	suppressed
Pregabalin	Pregabalin	15	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	13
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	15	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	14	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	14	suppressed
Spironolactone	Spironolactone	14	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	13	13
Rizatriptan	Rizatriptan Benzoate	13	suppressed
Testosterone	Testosterone	13	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	13	suppressed
Creon	Lipase/Protease/Amylase	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	12	suppressed
Invokana	Canagliflozin	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Methylphenidate Er	Methylphenidate Hcl	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error